Literature DB >> 35994175

Sexual Dysfunction After Traumatic Injury Can Be Corrected by Transcranial Magnetic Stimulation: A Case Report.

Xin Wang1, Yue-Ting Kang1, Xin-Yi Li1, Wei Liu1, Zhong-Liang Liu1, Bin Zheng2, Xiao-Qin Duan3,4.   

Abstract

Neurogenic sexual dysfunction (NSD) is a common problem in patients after spinal and pelvic trauma. New treatment is needed beyond medicine or psychological therapies. A 24-year-old man who fell from a six-floor building suffered from subsequent NSD. Repetitive transcranial magnetic stimulation (rTMS) was the only method used to treat his NSD caused by multiple spinal and pelvic injuries. The therapy lasted for 3 courses. Motor and sensory conduction, as well as sexual function, were evaluated before and after the rTMS intervention. Improvements on patient's nerve conduction and sexual activity were confirmed at a 1-year follow-up. Our findings indicate that rTMS delivered a novel, positive and low-cost modality treatment to the patient with NSD. Clinical efficacy and potential mechanisms by which rTMS regulate NSD need to be investigated by further clinical trials.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Neural conduction; Neurogenic sexual dysfunction; Neurological rehabilitation; Repetitive transcranial magnetic stimulation

Year:  2022        PMID: 35994175     DOI: 10.1007/s10508-022-02387-4

Source DB:  PubMed          Journal:  Arch Sex Behav        ISSN: 0004-0002


  11 in total

1.  The efficacy of regular penis-root masturbation, versus Kegel exercise in the treatment of primary premature ejaculation: A quasi-randomised controlled trial.

Authors:  Mingyang Jiang; Guanqiang Yan; Huachu Deng; Hao Liang; Yunni Lin; Xun Zhang
Journal:  Andrologia       Date:  2019-11-20       Impact factor: 2.775

2.  Cardiovascular differences between sham and active iTBS related to treatment response in MDD.

Authors:  Tabitha A Iseger; Martijn Arns; Jonathan Downar; Daniel M Blumberger; Zafiris J Daskalakis; Fidel Vila-Rodriguez
Journal:  Brain Stimul       Date:  2019-10-09       Impact factor: 8.955

3.  Sexual dysfunction among diabetics and its impact on the SQoL of their partners.

Authors:  W K B A Owiredu; H Alidu; N Amidu; C Obirikorang; C K Gyasi-Sarpong; A T Bawah; P P M Dapare; A T Luuse
Journal:  Int J Impot Res       Date:  2017-08-17       Impact factor: 2.896

4.  Magnetic stimulation of the cavernous nerve for the treatment of erectile dysfunction in humans.

Authors:  A Shafik; O el-Sibai; A A Shafik
Journal:  Int J Impot Res       Date:  2000-06       Impact factor: 2.896

Review 5.  Sex Differences in the Treatment of Sexual Dysfunction.

Authors:  Veronica Harsh; Anita H Clayton
Journal:  Curr Psychiatry Rep       Date:  2018-03-14       Impact factor: 5.285

Review 6.  A review of the potential of medicinal plants in the management and treatment of male sexual dysfunction.

Authors:  N Malviya; S Malviya; S Jain; S Vyas
Journal:  Andrologia       Date:  2016-10       Impact factor: 2.775

7.  Prediction of sexual function following spinal cord injury: a case series.

Authors:  J G Previnaire; J M Soler; M S Alexander; F Courtois; S Elliott; A McLain
Journal:  Spinal Cord Ser Cases       Date:  2017-12-13

8.  Dual-Site Transcranial Magnetic Stimulation for the Treatment of Parkinson's Disease.

Authors:  Christopher Fricke; Charlotte Duesmann; Timo B Woost; Judith von Hofen-Hohloch; Jost-Julian Rumpf; David Weise; Joseph Classen
Journal:  Front Neurol       Date:  2019-03-07       Impact factor: 4.003

9.  Effect of the combination of high-frequency repetitive magnetic stimulation and neurotropin on injured sciatic nerve regeneration in rats.

Authors:  Jie Chen; Xian-Ju Zhou; Rong-Bin Sun
Journal:  Neural Regen Res       Date:  2020-01       Impact factor: 5.135

Review 10.  Mechanisms of Transcranial Magnetic Stimulation Treating on Post-stroke Depression.

Authors:  Xiaoqin Duan; Gang Yao; Zhongliang Liu; Ranji Cui; Wei Yang
Journal:  Front Hum Neurosci       Date:  2018-05-30       Impact factor: 3.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.